By ThinkSabio #ThinkSabio US Market Morning Brief
Pre-Market Gainers:
$ASTI +271% – Ascent Solar Technologies enters a collaborative agreement with NASA to develop thin-film PV power beaming capabilities.
$CYN +126% – Cyngn highlights next-generation robotics, automation, and AI technologies at Automatica in collaboration with NVIDIA.
$VOR +107% – Vor Bio, a PureTech-founded entity, announces exclusive global license deal with RemeGen for a late-stage autoimmune asset and a $175 million private placement.
Pre-Market Decliners:
ALT -60% – Altimmune announces positive topline Phase 2b results for Pemvidutide in MASH, but stock falls—possibly due to high expectations.
$RVPH -38% – Reviva Pharmaceuticals announces a proposed public offering.
$GVH -34% – No fresh news; decline could be tied to earlier company developments or market sentiment.
Pre-Market Penny Gainers:
$ADIL +53% – Adial Pharmaceuticals secures U.S.-based manufacturing partnerships with Cambrex and Thermo Fisher for its drug supply chain (June 25).
$ASBP +32% – Aspire Biopharma announces last patient dosed in its Phase 1 trial of a fast-acting oral aspirin formulation (June 24).
$PSTV +24% – Plus Therapeutics provides a business update on its CNSide Diagnostics subsidiary.
Headlines:
$NVDA (NVIDIA) hits a record high, leading a tech rally despite concerns over tariffs and Fed policy.
$MSFT #AAPL #GOOGL #AVGO and #AMD are also trading near or at record highs.
$TSLA lags behind due to weak European sales.
Fed Chair Powell warns that tariff pressures may keep inflation elevated, suggesting rate cuts could be delayed.